OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA

OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA

Diabetic macular oedema, focal or diffuse, is primarily responsible for visual loss in cases of diabetic retinopathy. When to start photocoagulation in such cases has often been debatable. Over a 3 year period, 80 eyes of 80 patients were subjected to argon green macular grid photocoagulation in a r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical journal. Armed Forces India 1997-07, Vol.53 (3), p.195-198
Hauptverfasser: VATS, DP, DESHPANDE, M, BHARADWAJ, A, PHOOKEN, R, BANERJI, A, SAINI, JS, DASH, RG
Format: Artikel
Sprache:eng
Schlagworte:
Argon laser photocoagulation
Diabetic retinopathy
Original
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 198
container_issue 3
container_start_page 195
container_title Medical journal. Armed Forces India
container_volume 53
creator VATS, DP
DESHPANDE, M
BHARADWAJ, A
PHOOKEN, R
BANERJI, A
SAINI, JS
DASH, RG
description Diabetic macular oedema, focal or diffuse, is primarily responsible for visual loss in cases of diabetic retinopathy. When to start photocoagulation in such cases has often been debatable. Over a 3 year period, 80 eyes of 80 patients were subjected to argon green macular grid photocoagulation in a randomized clinical study keeping the other eye (80 eyes) as controls in patients with diabetic macular oedema. It was observed that in 5 per cent of such eyes the vision did improve while in 6.3 per cent of patients deterioration of vision was present as compared to 16.3 per cent in control group. It is concluded that laser photocoagulation has a definite role in arresting the progression of diabetic maculopathy and early intervention should be resorted to in case of clinically significant macular oedema.
doi_str_mv 10.1016/S0377-1237(17)30714-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5530973</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0377123717307141</els_id><sourcerecordid>1925896428</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2601-4eb8c9dea9c0c70e4dada394e8358772ca5e65a6b75aee76d3a2d21a73be313a3</originalsourceid><addsrcrecordid>eNqFkE9PwkAQxfegEUQ_gqZHPVR3u223vWhqWaFJoaSU6G2zbAetgRa7QOK3t_yR6MnTJG_eezP5IXRF8B3BxL0fY8qYSSzKbgi7pZgR2yQnqH2UW-hc6w-MqY1dcoZalsdc3_ZoG_Fkkhr8dcTTiA9DbrxEWd-IgzFPjVE_yZIwCXqTOMiiZGhEQ6MbBU88i0JjEISNnBoJ7_JBcIFOZ3Ku4fIwO2jyzLOwb8ZJLwqD2FSWi4lpw9RTfg7SV1gxDHYuc0l9GzzqeIxZSjrgOtKdMkcCMDen0sotIhmdAiVU0g562Pcu19MF5ArKVS3nYlkXC1l_iUoW4u-mLN7FW7URjkOxz2hTcHMoqKvPNeiVWBRawXwuS6jWWhDfcjzftS2vsTp7q6orrWuYHc8QLLbYxQ672PIVhIkddkGa3PXvH4-pH-aN4XFvgIbUpoBaaFVAqSAvalArkVfFPye-AQlkjsM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1925896428</pqid></control><display><type>article</type><title>OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA</title><source>Access via ScienceDirect (Elsevier)</source><source>PubMed Central</source><creator>VATS, DP ; DESHPANDE, M ; BHARADWAJ, A ; PHOOKEN, R ; BANERJI, A ; SAINI, JS ; DASH, RG</creator><creatorcontrib>VATS, DP ; DESHPANDE, M ; BHARADWAJ, A ; PHOOKEN, R ; BANERJI, A ; SAINI, JS ; DASH, RG</creatorcontrib><description>Diabetic macular oedema, focal or diffuse, is primarily responsible for visual loss in cases of diabetic retinopathy. When to start photocoagulation in such cases has often been debatable. Over a 3 year period, 80 eyes of 80 patients were subjected to argon green macular grid photocoagulation in a randomized clinical study keeping the other eye (80 eyes) as controls in patients with diabetic macular oedema. It was observed that in 5 per cent of such eyes the vision did improve while in 6.3 per cent of patients deterioration of vision was present as compared to 16.3 per cent in control group. It is concluded that laser photocoagulation has a definite role in arresting the progression of diabetic maculopathy and early intervention should be resorted to in case of clinically significant macular oedema.</description><identifier>ISSN: 0377-1237</identifier><identifier>DOI: 10.1016/S0377-1237(17)30714-1</identifier><identifier>PMID: 28769483</identifier><language>eng</language><publisher>India: Elsevier B.V</publisher><subject>Argon laser photocoagulation ; Diabetic retinopathy ; Original</subject><ispartof>Medical journal. Armed Forces India, 1997-07, Vol.53 (3), p.195-198</ispartof><rights>1997 Elsevier B.V. on behalf of Director General, Armed Forces Medical Services</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2601-4eb8c9dea9c0c70e4dada394e8358772ca5e65a6b75aee76d3a2d21a73be313a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530973/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0377-1237(17)30714-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3550,27924,27925,45995,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28769483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VATS, DP</creatorcontrib><creatorcontrib>DESHPANDE, M</creatorcontrib><creatorcontrib>BHARADWAJ, A</creatorcontrib><creatorcontrib>PHOOKEN, R</creatorcontrib><creatorcontrib>BANERJI, A</creatorcontrib><creatorcontrib>SAINI, JS</creatorcontrib><creatorcontrib>DASH, RG</creatorcontrib><title>OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA</title><title>Medical journal. Armed Forces India</title><addtitle>Med J Armed Forces India</addtitle><description>Diabetic macular oedema, focal or diffuse, is primarily responsible for visual loss in cases of diabetic retinopathy. When to start photocoagulation in such cases has often been debatable. Over a 3 year period, 80 eyes of 80 patients were subjected to argon green macular grid photocoagulation in a randomized clinical study keeping the other eye (80 eyes) as controls in patients with diabetic macular oedema. It was observed that in 5 per cent of such eyes the vision did improve while in 6.3 per cent of patients deterioration of vision was present as compared to 16.3 per cent in control group. It is concluded that laser photocoagulation has a definite role in arresting the progression of diabetic maculopathy and early intervention should be resorted to in case of clinically significant macular oedema.</description><subject>Argon laser photocoagulation</subject><subject>Diabetic retinopathy</subject><subject>Original</subject><issn>0377-1237</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkE9PwkAQxfegEUQ_gqZHPVR3u223vWhqWaFJoaSU6G2zbAetgRa7QOK3t_yR6MnTJG_eezP5IXRF8B3BxL0fY8qYSSzKbgi7pZgR2yQnqH2UW-hc6w-MqY1dcoZalsdc3_ZoG_Fkkhr8dcTTiA9DbrxEWd-IgzFPjVE_yZIwCXqTOMiiZGhEQ6MbBU88i0JjEISNnBoJ7_JBcIFOZ3Ku4fIwO2jyzLOwb8ZJLwqD2FSWi4lpw9RTfg7SV1gxDHYuc0l9GzzqeIxZSjrgOtKdMkcCMDen0sotIhmdAiVU0g562Pcu19MF5ArKVS3nYlkXC1l_iUoW4u-mLN7FW7URjkOxz2hTcHMoqKvPNeiVWBRawXwuS6jWWhDfcjzftS2vsTp7q6orrWuYHc8QLLbYxQ672PIVhIkddkGa3PXvH4-pH-aN4XFvgIbUpoBaaFVAqSAvalArkVfFPye-AQlkjsM</recordid><startdate>199707</startdate><enddate>199707</enddate><creator>VATS, DP</creator><creator>DESHPANDE, M</creator><creator>BHARADWAJ, A</creator><creator>PHOOKEN, R</creator><creator>BANERJI, A</creator><creator>SAINI, JS</creator><creator>DASH, RG</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199707</creationdate><title>OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA</title><author>VATS, DP ; DESHPANDE, M ; BHARADWAJ, A ; PHOOKEN, R ; BANERJI, A ; SAINI, JS ; DASH, RG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2601-4eb8c9dea9c0c70e4dada394e8358772ca5e65a6b75aee76d3a2d21a73be313a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Argon laser photocoagulation</topic><topic>Diabetic retinopathy</topic><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VATS, DP</creatorcontrib><creatorcontrib>DESHPANDE, M</creatorcontrib><creatorcontrib>BHARADWAJ, A</creatorcontrib><creatorcontrib>PHOOKEN, R</creatorcontrib><creatorcontrib>BANERJI, A</creatorcontrib><creatorcontrib>SAINI, JS</creatorcontrib><creatorcontrib>DASH, RG</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medical journal. Armed Forces India</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VATS, DP</au><au>DESHPANDE, M</au><au>BHARADWAJ, A</au><au>PHOOKEN, R</au><au>BANERJI, A</au><au>SAINI, JS</au><au>DASH, RG</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA</atitle><jtitle>Medical journal. Armed Forces India</jtitle><addtitle>Med J Armed Forces India</addtitle><date>1997-07</date><risdate>1997</risdate><volume>53</volume><issue>3</issue><spage>195</spage><epage>198</epage><pages>195-198</pages><issn>0377-1237</issn><abstract>Diabetic macular oedema, focal or diffuse, is primarily responsible for visual loss in cases of diabetic retinopathy. When to start photocoagulation in such cases has often been debatable. Over a 3 year period, 80 eyes of 80 patients were subjected to argon green macular grid photocoagulation in a randomized clinical study keeping the other eye (80 eyes) as controls in patients with diabetic macular oedema. It was observed that in 5 per cent of such eyes the vision did improve while in 6.3 per cent of patients deterioration of vision was present as compared to 16.3 per cent in control group. It is concluded that laser photocoagulation has a definite role in arresting the progression of diabetic maculopathy and early intervention should be resorted to in case of clinically significant macular oedema.</abstract><cop>India</cop><pub>Elsevier B.V</pub><pmid>28769483</pmid><doi>10.1016/S0377-1237(17)30714-1</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0377-1237
ispartof Medical journal. Armed Forces India, 1997-07, Vol.53 (3), p.195-198
issn 0377-1237
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5530973
source Access via ScienceDirect (Elsevier); PubMed Central
subjects Argon laser photocoagulation
Diabetic retinopathy
Original
title OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T04%3A07%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OUR%20EXPERIENCE%20WITH%20LASER%20PHOTOCOAGULATION%20IN%20DIABETIC%20MACULAR%20OEDEMA&rft.jtitle=Medical%20journal.%20Armed%20Forces%20India&rft.au=VATS,%20DP&rft.date=1997-07&rft.volume=53&rft.issue=3&rft.spage=195&rft.epage=198&rft.pages=195-198&rft.issn=0377-1237&rft_id=info:doi/10.1016/S0377-1237(17)30714-1&rft_dat=%3Cproquest_pubme%3E1925896428%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1925896428&rft_id=info:pmid/28769483&rft_els_id=S0377123717307141&rfr_iscdi=true